News Release

<< Back

SurModics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum

Webcast is Live on Thursday, November 19, at 11:40 a.m. (ET)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Nov. 11, 2015-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will make a presentation to the investment community at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York City on Thursday, November 19, 2015, at 11:40 a.m. ET (10:40 a.m. CT).

A live audio webcast of the presentation will be available by going to the investor relations portion of the Company’s website at www.surmodics.com and clicking on the webcast icon. An audio replay will be available beginning at noon CT on Thursday, November 19, and the webcast will be archived for 90 days.

About SurModics, Inc.
SurModics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. The company’s core offerings include surface modification coating technologies that impart lubricity, prohealing and biocompatibility characteristics and components for in vitro diagnostic test kits and microarrays. SurModics’ strategy is to build on the product and technical leadership within these fields, and expand the core offerings to generate opportunities for longer term sustained growth. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

Source: SurModics, Inc.

SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com